Vincent Fallet

2.5k total citations
45 papers, 679 citations indexed

About

Vincent Fallet is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Vincent Fallet has authored 45 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 30 papers in Oncology and 6 papers in Surgery. Recurrent topics in Vincent Fallet's work include Lung Cancer Treatments and Mutations (25 papers), Colorectal Cancer Treatments and Studies (11 papers) and Lung Cancer Diagnosis and Treatment (11 papers). Vincent Fallet is often cited by papers focused on Lung Cancer Treatments and Mutations (25 papers), Colorectal Cancer Treatments and Studies (11 papers) and Lung Cancer Diagnosis and Treatment (11 papers). Vincent Fallet collaborates with scholars based in France, United Kingdom and Spain. Vincent Fallet's co-authors include Marie Wislez, Jacques Cadranel, Martine Antoine, Thibault Vieira, J. Cadranel, M. Duruisseaux, Nathalie Rabbe, Anne-Marie Ruppert, A. Lavolé and Cécile Hamard and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Emerging infectious diseases.

In The Last Decade

Vincent Fallet

38 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Fallet France 14 538 472 103 100 85 45 679
Cinzia Baldessari Italy 13 207 0.4× 292 0.6× 102 1.0× 107 1.1× 50 0.6× 43 464
I. Garassino Italy 13 342 0.6× 271 0.6× 92 0.9× 106 1.1× 40 0.5× 28 547
Iveta Kudaba Latvia 14 490 0.9× 635 1.3× 61 0.6× 97 1.0× 72 0.8× 24 750
Matthew Chau Hsien Ng Singapore 14 170 0.3× 199 0.4× 159 1.5× 132 1.3× 74 0.9× 43 455
Luciano Wannesson Switzerland 14 174 0.3× 235 0.5× 112 1.1× 36 0.4× 67 0.8× 31 440
Pradeep Thanigaimani United States 7 175 0.3× 503 1.1× 71 0.7× 200 2.0× 56 0.7× 11 669
Manoj Shah India 11 112 0.2× 163 0.3× 121 1.2× 79 0.8× 65 0.8× 29 346
Nergiz Dağoğlu Türkiye 11 183 0.3× 244 0.5× 67 0.7× 170 1.7× 38 0.4× 35 440
Youhua Jiang China 14 244 0.5× 220 0.5× 162 1.6× 232 2.3× 149 1.8× 40 551

Countries citing papers authored by Vincent Fallet

Since Specialization
Citations

This map shows the geographic impact of Vincent Fallet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Fallet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Fallet more than expected).

Fields of papers citing papers by Vincent Fallet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Fallet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Fallet. The network helps show where Vincent Fallet may publish in the future.

Co-authorship network of co-authors of Vincent Fallet

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Fallet. A scholar is included among the top collaborators of Vincent Fallet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Fallet. Vincent Fallet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cadranel, Jacquès, et al.. (2025). Pulmonary toxicity of immune-checkpoint inhibitors. La Presse Médicale. 55(2). 104329–104329.
2.
Fallet, Vincent, et al.. (2023). PDL1-status predicts primary resistance of metastatic, EGFR-mutated non small cell lung cancers to EGFR tyrosine-kinase inhibitors. Respiratory Medicine and Research. 84. 101018–101018. 5 indexed citations
3.
Puszkiel, Alicja, Céline Narjoz, Jennifer Arrondeau, et al.. (2022). Exposure–Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer. Pharmaceutics. 14(9). 1844–1844. 18 indexed citations
4.
5.
Duruisseaux, M., Filippo Gustavo Dall’Olio, Patricia Iranzo, et al.. (2022). 34P RET-MAP: An international multi-center study on clinicopathologic features and treatment response in patients with NSCLC and RET fusions. Annals of Oncology. 33. S47–S48. 1 indexed citations
6.
Fallet, Vincent, Guido Ahle, Jennifer Arrondeau, et al.. (2022). Troubles du système nerveux central sous lorlatinib : comment les détecter et les gérer en pratique ?. Bulletin du Cancer. 109(4). 477–490.
7.
Wislez, Marie, Vincent Fallet, Jalal Assouad, et al.. (2021). Parcours de diagnostic rapide du cancer du poumon : évaluation à un an. Revue des Maladies Respiratoires. 38(9). 904–913. 3 indexed citations
8.
Fallet, Vincent, et al.. (2021). Local ablative therapy in oncogenic-driven oligometastatic non-small cell lung cancer: present and ongoing strategies—a narrative review. Translational Lung Cancer Research. 10(7). 3457–3472. 5 indexed citations
9.
Cadranel, J., Anthony Canellas, Antoine Parrot, et al.. (2019). Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer. European Respiratory Review. 28(153). 190058–190058. 69 indexed citations
10.
Cornélis, F., et al.. (2019). Percutaneous Image-Guided Electrochemotherapy of Spine Metastases: Initial Experience. CardioVascular and Interventional Radiology. 42(12). 1806–1809. 20 indexed citations
11.
Costantini, Adrien, Jennifer Corny, Vincent Fallet, et al.. (2018). Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer. ERJ Open Research. 4(2). 120–2017. 22 indexed citations
12.
13.
Vieira, Thibault, Martine Antoine, Cécile Hamard, et al.. (2016). Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages. Lung Cancer. 98. 51–58. 104 indexed citations
14.
Antoine, Martine, Thibault Vieira, Vincent Fallet, et al.. (2016). Carcinomes sarcomatoïdes pulmonaires. Annales de Pathologie. 36(1). 44–54. 19 indexed citations
15.
Fallet, Vincent, Raphaël Saffroy, Nicolas Girard, et al.. (2015). High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets. Annals of Oncology. 26(8). 1748–1753. 74 indexed citations
16.
Flippot, Ronan, Vincent Fallet, Benjamin Besse, et al.. (2015). Nivolumab, nouvel acteur majeur dans les cancers bronchiques non à petites cellules. Bulletin du Cancer. 102(12). 1046–1052. 1 indexed citations
17.
Vieira, Thibault, Martine Antoine, Anne-Marie Ruppert, et al.. (2014). Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung. Lung Cancer. 85(2). 276–281. 63 indexed citations
18.
Fallet, Vincent, Jacques Cadranel, H. Doubre, et al.. (2014). Prospective screening for ALK: Clinical features and outcome according to ALK status. European Journal of Cancer. 50(7). 1239–1246. 39 indexed citations
19.
Fallet, Vincent, Anne-Marie Ruppert, Virginie Poulot, et al.. (2012). Secondary Resistance to Erlotinib: Acquired T790M Mutation and Small-Cell Lung Cancer Transformation in the Same Patient. Journal of Thoracic Oncology. 7(6). 1061–1063. 16 indexed citations
20.
Fallet, Vincent, C. Toper, Martine Antoine, Jacques Cadranel, & Marie Wislez. (2012). Crizotinib, modalités pratiques d'un traitement personnalisé. Bulletin du Cancer. 99(7-8). 787–791. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cinzia Baldessari Breakdown of academic impact, for papers by I. Garassino Breakdown of academic impact, for papers by Iveta Kudaba Breakdown of academic impact, for papers by Matthew Chau Hsien Ng Breakdown of academic impact, for papers by Luciano Wannesson Breakdown of academic impact, for papers by Pradeep Thanigaimani Breakdown of academic impact, for papers by Manoj Shah Breakdown of academic impact, for papers by Nergiz Dağoğlu Breakdown of academic impact, for papers by Youhua Jiang
Rankless by CCL
2026